2 results for tag: drug patents


NHS Can’t Afford Half New Cancer Drugs

Half of new cancer drugs are too pricey for the NHS due to profiteering by drug companies. The Government is choosing to leave patients to die early rather than exercise its legal powers to obtain the newer, more effective drugs from a cheaper alternative source.

Cancer Drug Benefits Are Overhyped

Barely a month goes by without a newspaper headline hailing the latest “Major cancer breakthrough”, but dig beneath the media hype and you’ll discover the shocking reality that new cancer drugs for most cancers are only expected to improve patient survival by just 2.7 months on average.